2016 Trends to Lookout for Groundbreaking IVD tests

Today, ageing population is driving the demand for diagnostics worldwide. Other factors responsible for the expansion of IVD diagnostics market includes prevalence and incidence rise of certain conditions or diseases. Apart from this, increased focus by government bodies and third party players active in diagnostic testing market, have lowered healthcare costs and offered cost advantages. Changing lifestyle standards further create a higher demand for diagnostics in new markets and represent a protection against economic slowdown in mature market. 

However, industry experts at Allied Market Research (AMR) indicate that certain trends in 2016 would help the sector garner more profits. Concerns over emerging infectious conditions, advancements on sequencing as well as near patient DNA are among the popular trends that stakeholders and producers should lookout for in IVD testing this year. AMR’s report on “ In Vitro Diagnostics” is a great resource for business owners, product developers and marketing executives focused on exploring new prospects.

 
The IVD test service model is here to stay long. This model is rapidly becoming a prime channel for sophisticated molecular diagnostics. Earlier, the highly successful molecular diagnostics services provided cancer diagnostics applying ISH, PCR assessment of biopsied tissue as well as sequencing. Recent discoveries reveal that test services are also beneficial for cardiac risk genetics, autism and drug metabolism among other factors.

  
Secondly, 2016 would witness more acquisitions from key market players. Undoubtedly, IVD testing is complicated and prominent leaders would feel the need to access the technology they lack to remain competitive. In 2015 there were several acquisitions, collaborations and distribution agreements in the industry. Roche made waves in March 2015 by announcing its global distribution agreement for cellular analysis as well as conventional PCR uses with Sigma – Aldrich. The company also secured distribution agreement for proteomics and kits. Last year Roche emerged as a major stakeholder in Foundation Medicine. 

Thirdly, emerging disease threats would keep the IVD diagnostics market robust this year. Several conditions are making their presence worldwide a public health issue.  Diseases that were once believed to be just limited to demography or developing nations, they are now showing up across different countries and are among the highly complicates and deadly diseases to curb and control. Ebola threat has finally awakened masses in America to pandemic conditions and created new avenues for approvals of many test devices.

Eyeing the opportunities created in the industry due to invasive and non -invasive diagnostic procedure, research analysts have published a report titled “World In Vitro Diagnostics Market (IVD) - Opportunities and Forecasts, 2014 – 2020.” Analysis conducted in the report provides a wider view of the market share and size, restraint and opportunities. Study covers all the key techniques, end -user, applications product types, usability and geography. Business owners planning on expanding their reach would benefit from the information on the competitive landscape and effective marketing channels. 

Related Post